| Tag | Content |
|---|
EnhancerAtlas ID | HS073-03744 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr13:50103750-50105820 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| DUX4 | MA0468.1 | chr13:50104894-50104905 | TAATCCAATCA | + | 6.02 | | Nr2f6(var.2) | MA0728.1 | chr13:50103969-50103984 | CGATCTCTTGACCTC | - | 6 | | ZIC3 | MA0697.1 | chr13:50105722-50105737 | CACCTCCCGCTGTGC | + | 6.38 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_18710 | chr13:50104065-50105408 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_58752 | chr13:50095609-50116193 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr13 | 50104019 | 50104200 | | chr13 | 50104600 | 50105215 | | chr13 | 50105195 | 50105259 | | chr13 | 50104200 | 50104273 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I049529 | chr13 | 50104055 | 50105764 |
|
Enhancer Sequence | TTGTTGTTTT GTTTTGTTTA AGACGGAGTC TCACTTTGTT GCCAGGCTGG AGTGCAGTGG 60
TGTGATCTCG GCTCACTGCA ACCTCTGCCT CCTAGGTTCA AGCGATTCTC CTGCCTCAGC 120
CTCCCAAGTA GCTGGGACTA CAGGCGCGCA CCACCATGCC CAGCTAATTT TTGTATTTTT 180
AGTAGAGATG GGGTTTCACC ATGTTGGCCA GGATGGTCTC GATCTCTTGA CCTCGTGATC 240
TGCCTGCCTC GGCCTCCCAA AGTGCTGGGA TTACAGGCGT GAGCCACCAC GCCCAGCCAT 300
CTTAGCAAAG TTTATCTGAC TAATCATTCT GATGTCATGA TCTTTATTTA AAAAAAAAAA 360
CCTTTGTCCC CCACTTTACT TTCACGTTTA ACCTGTGACT CACACAGCAT GTAACTGTGC 420
ACCATGGAGC ACCATGTGTT TGGTGGCCAT GAGGCTGGCT ACTGGGCAAA CCCGAGTATG 480
GGTTCATAAG GCGGAGCCGA GTATGAACTT CAGCTATGTC ACTACTGAAA AACTTGAATC 540
CGATTATTTA ATCTGAGAAT GCTGCTGCCT ACCTTATGGG ACAAAATATG GACAAGTAAG 600
TAAAATGTGA AGCAGAGAGC ACAATGTCTG GCACTATGGG AAATAAATGT TAAAACACAC 660
CCATGCACGC ACACACTCCC CTTGCTAACA TTTCTGTCTT ATTTTCTCCA TTCTAACCAA 720
ACTTAATTAT GATAAGCTCT GGAAGGCTCA TTAGCCCCCA TCTCTTGTGC CTCTTTTTGT 780
TTTGGAGATG AGCTAAAAGG ACACTTTATA TTTTCCCCTA TCCAACACAA GCGTTATCTT 840
CAGAACAACT AACTGCTTGT CATGTTAACC CTATTAACTG TATTAGTCCG TTCTCACACT 900
GGTATGAAGA AATACCAGAG ACTGGGTAAT TTATAAAGGA AACAGGTTTA ATGGACTCAG 960
TTCCGCATGG CTGGGGAGGT CTCAAGAAAC TTACAATTGT GGCGGAAAGG GAAGAGGCCC 1020
GTCTTACGTA GTGGCAAGTA AGTGAGAGCA CGCAAAGCCC AGGGGGAACT GCCATTTATA 1080
AAACCATCAG ATCTCATAAG AACTCCCTCA ATAGCATGAG AACAGCATGG GGAAACCGCC 1140
CCCATAATCC AATCACCTCC CAACAGGTCT CCCTCAACAA CTGAGGATTA CAATTCAAGA 1200
TAAGTTGGGT GGGGACACAG AGCCAAACCA CATCATCCTA TTTGGTTTTC TCTCACTGAC 1260
TGTTATGAAA AGCTCTTTAT AAGTATCTCA TTGTGTTGTT AATTCCTAAA CCTATCTCCC 1320
TCTCTCCTAA TAATTCATAT GTTCTTTGAG GATAGGGAAT ATGCCTTTCC CTTCAAGTAC 1380
CCCCAAAGGT ACAGACACAT TTTTCTACTG TGCCAGTTCA ACTGTACTAC CCTTCAGCAG 1440
GAATAAAATC CAAAGATTTC TATGATGTTT GTTTGTGTAT AGTTGAGAAT CAAGCAGTTG 1500
ACATGTTCAT GCTGGTACCT ATTTTTAGCC TGATACCCAT TAAGAATCAC ACCACTGATT 1560
TTTTTTATTA TGGTAAAATA TATATATAAC CTAAAATTTG CCATCCCAAT CATTTTTAAA 1620
TGTATGGTTC AATGGCATTA AACATTCATT TTTGTGCAAC CATCACCACC ATGCACCTAA 1680
AGCAGCAGTC CCCAACCTTT TTGGCACCAG GGACTGGTTT CGTGGAAGAC AATTTTTCCA 1740
CGGACCATGG GGATGGGGCG GTTGGTCAGG GGTGGGGAGG ATGGTTTTGG GATGAAATTG 1800
GTCCACCTCA GATCACCAGT CATTAGATTC TCATATGGAG CACACAACCT AGATCCCTTG 1860
CATACTCAGT TCACTGTAGG GTTTGCACTC CTATGAGAAT CTAATGTTCT AATGTTGCCA 1920
CTGATCTGAC AGGAGGCAGA ACTCAGGCAG TAATGCTCAC TCATCCGCCA CTCACCTCCC 1980
GCTGTGCGAC CTCTTCCTAA CACGCCAGGG ATGAATATGG GTCTGTGGCC CGAGGGTTGG 2040
GGACCCCTGA CCTAAAGGAC TCTTCATCTT 2070
|
